Exagen Inc. (the "Company") held its 2021 annual meeting of stockholders (the "Annual Meeting") on June 17, 2021. At the Annual Meeting, the Company's stockholders voted on two proposals, as described below. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 27, 2021. The vote totals noted below are final voting results from the Annual Meeting.
The Company's stockholders elected the following two Class II directors for a three-year term of office expiring at the Company's 2024 annual meeting of stockholders and until their successors are duly elected and qualified or until such director's earlier death, resignation or removal.
Vot es Withheld
James L.L. Tullis
The Company's stockholders ratified the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 21, 2021
/s/ Kamal Adawi
Chief Financial Officer
makes a similar move, sign up!